Medicare Expands Access to Weight Loss Medications for Beneficiaries
Starting Wednesday, Medicare beneficiaries can obtain weight loss medications like Wegovy and Zepbound for $50 per month. However, it's crucial for individuals interested in immediate or long-term access to manage their expectations. Insurance carriers and healthcare providers should anticipate regulatory compliance requirements that could impact approval timelines.